Abnormal expression of clock genes, including Baml1, Clock, and Dbp, was improved in the hypothalamus, and ameliorated pathogenesis of neurodegeneration was also observed in AD mice with dual treatment. This evidence concerns the gene DBP and Alzheimer disease.